Lipoid pneumonia epidemiology and demographics

Revision as of 20:07, 18 October 2019 by Ramyar (talk | contribs)
Jump to navigation Jump to search


Lipoid pneumonia Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Lipoid pneumonia from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Interventions

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Lipoid pneumonia epidemiology and demographics On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Lipoid pneumonia epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Lipoid pneumonia epidemiology and demographics

CDC on Lipoid pneumonia epidemiology and demographics

Lipoid pneumonia epidemiology and demographics in the news

Blogs on Lipoid pneumonia epidemiology and demographics

Directions to Hospitals Treating Psoriasis

Risk calculators and risk factors for Lipoid pneumonia epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ramyar Ghandriz MD[2]

Overview

The incidence and prevalence of lipoid pneumonia are underestimated. It is mostly because of similarities between pneumonias from different causes and lack of specific marker to distinguish pneumonias from each other. In 2019 there was an outbreak of vaping based pulmonary complications.

Epidemiology and Demographics

Incidence

  • In 2019 there was an outbreak of vaping based pulmonary complications.
  • the majority of underlying cause of morbidity was lipoid pneumonia.
  • The incidence of cases differentiated based on state can be seen on :"Outbreak of Lung Injury Associated with E-Cigarette Use, or Vaping".
  • The incidence and prevalence of lipoid pneumonia are underestimated. It is mostly because of similarities between pneumonias from different causes and lack of specific marker to distinguish pneumonia from each other.[1]
  • There is no prediction of incidence of lipoid pneumonia but the incidence of aspiration pneumonia is approximately 300,000 to 600,000 individuals annually in the United States.[2]

Prevalence

  • There is no study about prevalence of lipoid pneumonia.

Mortality rate

  • Prognosis of lipoid pneumonia is usually indolent, however, it may also be progressive.[3]
  • lipoid pneumonia is not usually a cause of death, instead the complications such as superinfection, cor pulmonale or lung cancer are mortal.

Age

Gender

References

  1. Lanspa, Michael J.; Jones, Barbara E.; Brown, Samuel M.; Dean, Nathan C. (2013). "Mortality, morbidity, and disease severity of patients with aspiration pneumonia". Journal of Hospital Medicine. 8 (2): 83–90. doi:10.1002/jhm.1996. ISSN 1553-5592.
  2. Marik, Paul E. (2001). "Aspiration Pneumonitis and Aspiration Pneumonia". New England Journal of Medicine. 344 (9): 665–671. doi:10.1056/NEJM200103013440908. ISSN 0028-4793.
  3. Gondouin, A.; Manzoni, Ph.; Ranfaing, E.; Brun, J.; Cadranel, J.; Sadoun, D.; Cordier, J.F.; Depierre, A.; Dalphin, J.C. (1996). "Exogenous lipid pneumonia: a retrospective multicentre study of 44 cases in France". European Respiratory Journal. 9 (7): 1463–1469. doi:10.1183/09031936.96.09071463. ISSN 0000-0000.